We are live on
!
Find out more
MC
Mayo Clinic Portfolio holdings
AUM
$2.9M
1-Year Est. Return
14.49%
This Fund
S&P 500
This Quarter
Est. Return
+49.04%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$65M
(+164%)
Cap. Flow
+$42.9M
Cap. Flow
% of AUM
41.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$26.5M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STEX
Streamex Corp
STEX
|
+$402K |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$220K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.65% |
| 2 | Energy | 35.52% |
| 3 | Miscellaneous | 26.76% |
| 4 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Black Stone Minerals
BSM
$3.15B
| $37.1M | 35.52% |
5,711,137
| – | – |
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$825B
| $28M | 26.76% |
+90,686
| New | +$26.5M |
|
|
3
Zentalis Pharmaceuticals
ZNTL
$359M
| $21.3M | 20.34% |
+442,713
| New | +$17M |
|
|
UBX
4
DELISTED
Unity Biotechnology
UBX
| $13.6M | 13.06% |
157,198
| – | – |
|
|
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $2.38M | 2.27% |
24,248
| – | – |
|
|
STEX
6
Streamex Corp
STEX
$88.1M
| $1.13M | 1.08% |
15,638
-4,620
| -23% | -$402K |
|
7
Seres Therapeutics
MCRB
$50.8M
| $857K | 0.82% |
9,000
| – | – |
|
8
ClearPoint Neuro
CLPT
$475M
| $168K | 0.16% |
47,148
| – | – |
|
|
VYNT
9
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1K | ﹤0.01% |
89
| – | – |
|
|
EXAS
10
DELISTED
Exact Sciences
EXAS
| – | – |
-3,795
| Closed | -$220K |
|
Similar funds
SWS
PWA
CU
QC
SOA
HVM
JC
MIG
Mayo Clinic's Q2 2020 Portfolio in Review
As of Q2 2020, Mayo Clinic held 10 positions worth $105M, up 164% from $39.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mayo Clinic deployed $42.9M of net new capital in Q2 2020, opening 2 new positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 90,686 shares worth $28M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 30% a quarter earlier, followed by Energy and Miscellaneous.
On the sell side, the largest reduction was Streamex Corp, an estimated $402K trimmed.
- Mayo Clinic's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 90,686 shares worth $28M.
- Mayo Clinic's biggest Q2 2020 reduction was Streamex Corp, cutting an estimated $402K.
- Mayo Clinic fully exited Exact Sciences in Q2 2020, selling an estimated $220K.
- Mayo Clinic's ten largest holdings make up 100% of its $105M portfolio in Q2 2020.
- Mayo Clinic opened 2 new positions and closed 1 in Q2 2020.
- Mayo Clinic's portfolio value rose 164% quarter-over-quarter to $105M.
Based on Mayo Clinic's 13F filing for Q2 2020, filed 13 Aug 2020.